[{"NetIncomeLoss_1_Q3_USD":-40952.0,"DueToRelatedPartiesCurrent_0_Q3_USD":4334.0,"SaleOfStockPricePerShare_0_Q3_USD":10.0,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_1_Q3_USD":2000000.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0_Q3_USD":5000001.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":94358060.0,"AdministrativeFeesExpense_1_Q3_USD":4334.0,"AssetsCurrent_0_Q3_USD":1346984.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":25000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q3_USD":-100000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":2888352.0,"Assets_0_Q3_USD":101324807.0,"PreferredStockSharesOutstanding_0_Q3_shares":null,"Liabilities_0_Q3_USD":1966737.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1316314.0,"IncreaseDecreaseInAccountsPayable_1_Q3_USD":27062.0,"PaymentsOfStockIssuanceCosts_1_Q3_USD":329713.0,"StockIssuedDuringPeriodValueOther_1_Q3_USD":-329713.0,"NetCashProvidedByUsedInFinancingActivities_1_Q3_USD":101334363.0,"ProceedsFromIssuanceOfPrivatePlacement_1_Q3_USD":3550000.0,"BusinessAcquisitionPercentageOfVotingInterestsAcquired_0_Q3_pure":0.5,"FederalDepositInsuranceCorporationPremiumExpense_1_Q3_USD":250000.0,"BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0_Q3_USD":4175978.0,"PrepaidExpenseCurrent_0_Q3_USD":30670.0,"ProceedsFromRelatedPartyDebt_1_Q3_USD":89076.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q3_USD":94358060.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_1_Q3_USD":25000.0,"PreferredStockSharesIssued_0_Q3_shares":null,"OtherUnderwritingExpense_1_Q3_USD":1846265.0,"AdditionalPaidInCapital_0_Q3_USD":5040582.0,"AmortizationOfDeferredLeasingFees_1_Q3_USD":1846265.0,"NonoperatingIncomeExpense_1_Q3_USD":-22177.0,"AccountsPayableCurrent_0_Q3_USD":27062.0,"LiabilitiesCurrent_0_Q3_USD":120472.0,"OtherCostAndExpenseOperating_0_Q3_USD":329713.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":99977823.0,"NetCashProvidedByUsedInOperatingActivities_1_Q3_USD":-18049.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-22177.0,"PaymentsForUnderwritingExpense_0_Q3_USD":2000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q3_USD":1316314.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-40952.0,"SharesOutstanding_0_Q3_shares":2875000.0,"IncreaseDecreaseInDueToRelatedParties_1_Q3_USD":4334.0,"GainLossOnCondemnation_1_Q3_USD":-18775.0,"StockholdersEquity_0_Q3_USD":5000010.0,"DeferredOfferingCosts_0_Q3_USD":329713.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.01,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":101324807.0,"PreferredStockValue_0_Q3_USD":null,"ProceedsFromIssuanceInitialPublicOffering_1_Q3_USD":98000000.0,"OperatingIncomeLoss_1_Q3_USD":-18775.0,"IncreaseDecreaseInPrepaidExpense_1_Q3_USD":30670.0,"DebtorInPossessionFinancingBorrowingsOutstanding_0_Q3_USD":89076.0,"Ticker":"HUMA","CIK":"1818382","name":"ALPHA HEALTHCARE ACQUISITION CORP.","OfficialName":"Humacyte Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"762233833.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201113"}]